Carlos A Zarate, M.D.
National Institute of Mental Health (NIMH)
19
19
8
N/A
0
34
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+17 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (19)
Showing 10 of 19 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Urielle Desalbres
Assistance Publique HĂ´pitaux de Marseille
Shared therapeutic areas:
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Joseph Biederman, MD
Massachusetts General Hospital
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
General Manager
Tanabe Pharma Corporation
Shared therapeutic areas:
Elliot Stein, Ph.D.
National Institute on Drug Abuse (NIDA)
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (19)
Showing 19 of 19 trials
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
Antidepressant Effects of TS-161 in Treatment-Resistant Depression
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes
Development of Non-Invasive Brain Stimulation Techniques
Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Main Study: Influence on Plasticity of Brain Temperature Sub-Study: Phase Triggered Paired Associative Stimulation (PAS)
Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder
Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
Riluzole to Treat Depression in Bipolar Disorder
Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies
Lexapro and Pramipexole and to Treat Major Depression
Rapid Antidepressant Effects of Ketamine in Major Depression
p11 Protein Levels in Patients With Major Depressive Disorder Treated With Citalopram
Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive Disorder
Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?
All 19 trials loaded